Autres langues Spectral AI, Inc.

Actions

MDAI

US84757T1051

Equipement et technologie médicale avancés

Marché Fermé - 22:00:00 24/09/2026 Varia. 5j. Varia. 1 janv.
1,620 USD -2,41% Graphique intraday de Spectral AI, Inc. +1,89% +14,08%

Autres langues

24/09 Spectral AI Announces Upcoming Presentation at ACS Clinical Congress 2026 Highlighting the Use of Artificial Intelligence and Multi-Spectral Imaging in the Assessment of Burn Wounds
24/09 Spectral Ai, Inc. Announces Upcoming Presentation At ACS Clinical Congress 2026 Highlighting the Use of Artificial Intelligence and Multi-Spectral Imaging in the Assessment of Burn Wounds
16/09 Spectral AI Showcases DeepView® System for Burn Indication and KOL Research at Southern Regional Burn Conference
01/09 Spectral AI to Present at H.C. Wainwright 28th Annual Global Investment Conference
11/08 Spectral AI Announces 2026 Second Quarter Financial Results
11/08 Spectral Ai, Inc. Reiterates Revenue Guidance for the Year Ending December 31, 2026
11/08 Spectral AI, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
29/07 Spectral AI Schedules 2026 Second Quarter Financial Results and Conference Call
08/07 Spectral Ai, Inc. Announces Appointment of Darcy Bajko to Chief Commercial Officer, Effective July 31, 2026
08/07 Spectral AI Names Darcy Bajko Chief Commercial Officer to Lead Global Sales Launch of FDA-Cleared DeepView® System for Burn Indication
29/06 Spectral AI, Inc.(NasdaqCM:MDAI) added to Russell Microcap Value Benchmark Index
29/06 Spectral AI, Inc.(NasdaqCM:MDAI) added to Russell 3000E Value Benchmark
25/06 DeepView® System Highlighted at the 2026 British Burn Association Annual Conference
12/06 Spectral AI Joins the American Board of Wound Management Foundation in Celebrating Wound Healing Awareness Month
11/06 Spectral AI to Participate in 2026 British Burn Association Annual Conference
01/06 Spectral AI Announces Voting Results of Annual Meeting of Stockholders
26/05 Spectral Ai Receives FDA De Novo Clearance for DeepView System for Burn Indication
26/05 Spectral Ai receives FDA De Novo clearance for Deepview® system for burn indication
26/05 Spectral AI Receives FDA De Novo Clearance for DeepView® System for Burn Indication
26/05 Spectral AI Receives FDA De Novo Clearance for DeepView® System for Burn Indication
12/05 Spectral AI Inc - forecasts FY2026 revenue of about $18.5 million
12/05 Spectral AI Announces 2026 First Quarter Financial Results
12/05 Spectral AI Announces 2026 First Quarter Financial Results
12/05 Spectral AI, Inc. Reiterates Revenue Guidance for the Year Ending December 31, 2026
12/05 Spectral AI, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026
Aucun résultat pour cette recherche